Fact Based List:

Vizient: Top 10 drugs by Total Spend Among Members

Submitted by Charlene Ice on Mon, 02/03/2020 - 12:23


  1. Adalimumab (Humira)
  2. Rituximab (Rituxan)
  3. Infliximab (Remicade)
  4. Pembrolizumab (Keytruda)
  5. Etanercept (Enbrel)
  6. Ustekinumab (Stelara)
  7. Nivolumab (Opdivo)
  8. Pegfilgrastim (Neulasta)
  9. Alteplase (Activase, Cathflo)
  10. Denosumab (Prolia, Xgeva)

Notes: Based on Vizient member data for October 1, 2018 through September 30, 2019.
Source: Vizient, January 2020
Source URL: https://www.vizientinc.com/-/media/documents/sitecorepublish...



List Ratings:   
0
No votes yet
Your rating: None

Lists You Might Also Be Interested In



    Login or register to post comments